GANNON STEVEN
CIK: 0001643085
Director
Primary company: Xenon Pharmaceuticals Inc. (XENE)
GANNON STEVEN is a corporate insider at Xenon Pharmaceuticals Inc. (XENE) filing SEC Form 4 transactions. 43 transactions across 2 companies, totaling $229,115 in purchases and $601,706 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 1,593 | - | - | 1,593 | 6/3/2026 Filed: 6/1/2026 | Filing → | |
| Award | 10,507 | $53.46 | $562K | 10,507 | 6/3/2026 Filed: 6/1/2026 | Filing → | |
| Exercise | 2,645 | - | - | 0 | 6/1/2026 Filed: 6/1/2026 | Filing → | |
| Tax Payment | 1,416 | $53.41 | $76K | 11,870 | 6/1/2026 Filed: 6/1/2026 | Filing → | |
| Exercise | 2,645 | - | - | 13,286 | 6/1/2026 Filed: 6/1/2026 | Filing → | |
| Exercise | 3,500 | $7.38 | $26K | 0 | 5/12/2026 Filed: 5/12/2026 | Filing → | |
| Exercise | 3,500 | $7.38 | $26K | 10,641 | 5/12/2026 Filed: 5/12/2026 | Filing → | |
| Award | 2,645 | - | - | 2,645 | 6/5/2025 Filed: 6/6/2025 | Filing → | |
| Award | 17,012 | - | - | 17,012 | 6/5/2025 Filed: 6/6/2025 | Filing → | |
| Sale | 3 | $30.48 | $91 | 7,141 | 6/5/2025 Filed: 6/6/2025 | Filing → | |
| Exercise | 5,144 | - | - | 0 | 5/14/2025 Filed: 5/16/2025 | Filing → | |
| Exercise | 5,144 | $12.57 | $65K | 7,144 | 5/14/2025 Filed: 5/16/2025 | Filing → | |
| Award | 15,542 | - | - | 15,542 | 6/5/2024 Filed: 6/5/2024 | Filing → | |
Fusion Pharmaceuticals Inc. FUSN | Disposition | 17,000 | - | - | 0 | 6/4/2024 Filed: 6/4/2024 | Filing → |
Fusion Pharmaceuticals Inc. FUSN | Disposition | 17,000 | - | - | 0 | 6/4/2024 Filed: 6/4/2024 | Filing → |
Fusion Pharmaceuticals Inc. FUSN | Disposition | 17,000 | - | - | 0 | 6/4/2024 Filed: 6/4/2024 | Filing → |
Fusion Pharmaceuticals Inc. FUSN | Disposition | 30,000 | - | - | 0 | 6/4/2024 Filed: 6/4/2024 | Filing → |
Fusion Pharmaceuticals Inc. FUSN | Disposition | 141,011 | - | - | 0 | 6/4/2024 Filed: 6/4/2024 | Filing → |
Fusion Pharmaceuticals Inc. FUSN | Disposition | 56,400 | - | - | 0 | 6/4/2024 Filed: 6/4/2024 | Filing → |
| Sale | 2,000 | $46.20 | $92K | 2,000 | 3/7/2024 Filed: 3/8/2024 | Filing → |
Type
Award
Shares
1,593
Price
-
Value
-
Type
Award
Shares
10,507
Price
$53.46
Value
$562K
Type
Exercise
Shares
2,645
Price
-
Value
-
Type
Tax Payment
Shares
1,416
Price
$53.41
Value
$76K
Type
Exercise
Shares
2,645
Price
-
Value
-
Type
Exercise
Shares
3,500
Price
$7.38
Value
$26K
Type
Exercise
Shares
3,500
Price
$7.38
Value
$26K
Type
Award
Shares
2,645
Price
-
Value
-
Type
Award
Shares
17,012
Price
-
Value
-
Type
Sale
Shares
3
Price
$30.48
Value
$91
Type
Exercise
Shares
5,144
Price
-
Value
-
Type
Exercise
Shares
5,144
Price
$12.57
Value
$65K
Type
Award
Shares
15,542
Price
-
Value
-
Fusion Pharmaceuticals Inc.
FUSN
Type
Disposition
Shares
17,000
Price
-
Value
-
Fusion Pharmaceuticals Inc.
FUSN
Type
Disposition
Shares
17,000
Price
-
Value
-
Fusion Pharmaceuticals Inc.
FUSN
Type
Disposition
Shares
17,000
Price
-
Value
-
Fusion Pharmaceuticals Inc.
FUSN
Type
Disposition
Shares
30,000
Price
-
Value
-
Fusion Pharmaceuticals Inc.
FUSN
Type
Disposition
Shares
141,011
Price
-
Value
-
Fusion Pharmaceuticals Inc.
FUSN
Type
Disposition
Shares
56,400
Price
-
Value
-
Type
Sale
Shares
2,000
Price
$46.20
Value
$92K
AI Agent
Try asking...